Hydrogel Endovascular Aneurysm Treatment Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 600 participants.

Also called NCT01407952

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 600 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01407952
Other papers using this trial's data
  • The Hydrogel Endovascular Aneurysm Treatment Trial (HEAT): A Randomized Controlled Trial of the Second-Generation Hydrogel Coil Neurosurgery, 2020-05-01 DOI, PubMed 32078692, PMC7534546 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01407952. Randomized; no masking; primary purpose treatment. Start 2012-04 (registry gives no type); primary completion 2018-03 (actual). Results posted on 2019-06-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hydrogel Endovascular Aneurysm Treatment Trial
Acronym
HEAT
Condition
Cerebral Aneurysm
Intervention (Device)
HydroCoil Embolic System
Intervention (Device)
Control (bare platinum coils)
Lead sponsor
Northwestern University (class: other)
Collaborator
MicroVention, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01407952
Content hash
8b70fa93f4e3bc449d4531aad496bebe6db88013f7d0292c4b15b1772a6d8dcf